387 related articles for article (PubMed ID: 32973449)
21. A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer's Disease.
Mishra S; Stany B; Das A; Kanagavel D; Vijayan M
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38558361
[TBL] [Abstract][Full Text] [Related]
22. Identifying circRNA-associated-ceRNA networks in the hippocampus of Aβ1-42-induced Alzheimer's disease-like rats using microarray analysis.
Wang Z; Xu P; Chen B; Zhang Z; Zhang C; Zhan Q; Huang S; Xia ZA; Peng W
Aging (Albany NY); 2018 Apr; 10(4):775-788. PubMed ID: 29706607
[TBL] [Abstract][Full Text] [Related]
23. Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites.
Navas-Carrillo D; Rivera-Caravaca JM; Sampedro-Andrada A; Orenes-Piñero E
Crit Rev Clin Lab Sci; 2021 May; 58(3):167-179. PubMed ID: 33137264
[TBL] [Abstract][Full Text] [Related]
24. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
27. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
28. Blood circulating miRNAs as biomarkers of Alzheimer's disease: a systematic review and meta-analysis.
Zhang YH; Bai SF; Yan JQ
Biomark Med; 2019 Aug; 13(12):1045-1054. PubMed ID: 31385521
[No Abstract] [Full Text] [Related]
29. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
Dehghani R; Rahmani F; Rezaei N
Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
[TBL] [Abstract][Full Text] [Related]
30. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs as Therapeutic Targets for Alzheimer's Disease.
Di Meco A; Praticò D
J Alzheimers Dis; 2016 May; 53(2):367-72. PubMed ID: 27163828
[TBL] [Abstract][Full Text] [Related]
32. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
33. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
34. Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia.
Dong X; Zheng D; Nao J
Front Aging Neurosci; 2020; 12():580199. PubMed ID: 33093831
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
[TBL] [Abstract][Full Text] [Related]
36. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.
Millan MJ
Prog Neurobiol; 2017 Sep; 156():1-68. PubMed ID: 28322921
[TBL] [Abstract][Full Text] [Related]
37. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
Engelborghs S
Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
[TBL] [Abstract][Full Text] [Related]
38. The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer's Disease.
Zhao J; Yue D; Zhou Y; Jia L; Wang H; Guo M; Xu H; Chen C; Zhang J; Xu L
Front Neurol; 2017; 8():342. PubMed ID: 28769871
[TBL] [Abstract][Full Text] [Related]
39. The Regulation of microRNAs in Alzheimer's Disease.
Kou X; Chen D; Chen N
Front Neurol; 2020; 11():288. PubMed ID: 32362867
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
